FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4363625980> ?p ?o ?g. }

• W4363625980 endingPage "e834" @default.
• W4363625980 startingPage "e823" @default.
• W4363625980 abstract "Loss of PTEN function leads to increased PI3Kβ signaling. AZD8186, a selective PI3Kβ/δ inhibitor, has shown anti-tumor activity in PTEN-deficient preclinical models. Although the combination of AZD8186 and paclitaxel was well tolerated, limited clinical efficacy was observed in advanced gastric cancer with PTEN loss.In the phase Ib dose-escalation, subjects with advanced solid tumors received oral AZD8186 (60 mg or 120 mg; twice daily (BID); 5 days on/2 days off) plus intravenous paclitaxel (70 mg/m2 or 80 mg/m2; days 1, 8, and 15) every 4 weeks. In the phase II part, MRGC patients with PTEN loss or PTEN/PIK3CB gene abnormality were enrolled and received recommended phase II dose (RP2D) of AZD8186 plus paclitaxel. Primary endpoints were to determine maximum tolerated dose (MTD) and RP2D in phase Ib and 4-month progression-free survival (PFS) rate in phase II.In phase Ib, both MTD and RP2D were determined at paclitaxel 80 mg/m2 and AZD8186 120 mg BID. In phase II, 18 patients were enrolled [PTEN loss (n = 18) and PIK3CB mutation (n = 1)]. The 4-month PFS rate was 18.8% (3 of 16 evaluable patients) and further enrollment stopped due to futility.Although the combination of AZD8186 and paclitaxel was well tolerated, limited clinical efficacy was observed.ClinicalTrials.gov Identifier: NCT04001569." @default.
• W4363625980 created "2023-04-11" @default.
• W4363625980 creator A5008643924 @default.
• W4363625980 creator A5010584350 @default.
• W4363625980 creator A5016948885 @default.
• W4363625980 creator A5033087588 @default.
• W4363625980 creator A5042301449 @default.
• W4363625980 creator A5052958094 @default.
• W4363625980 creator A5069823694 @default.
• W4363625980 creator A5082985646 @default.
• W4363625980 creator A5084847095 @default.
• W4363625980 creator A5084870834 @default.
• W4363625980 creator A5085952795 @default.
• W4363625980 creator A5091554389 @default.
• W4363625980 date "2023-04-10" @default.
• W4363625980 modified "2023-10-18" @default.
• W4363625980 title "AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20)" @default.
• W4363625980 cites W1984418041 @default.
• W4363625980 cites W1991780505 @default.
• W4363625980 cites W2077582389 @default.
• W4363625980 cites W2100439220 @default.
• W4363625980 cites W2111237964 @default.
• W4363625980 cites W2145722025 @default.
• W4363625980 cites W2149307190 @default.
• W4363625980 cites W2167009545 @default.
• W4363625980 cites W2430137238 @default.
• W4363625980 cites W2736216151 @default.
• W4363625980 cites W2780016255 @default.
• W4363625980 cites W2910775131 @default.
• W4363625980 cites W3037176520 @default.
• W4363625980 cites W3037647656 @default.
• W4363625980 cites W3127040939 @default.
• W4363625980 cites W3147820834 @default.
• W4363625980 cites W3171517418 @default.
• W4363625980 doi "https://doi.org/10.1093/oncolo/oyad059" @default.
• W4363625980 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37036671" @default.
• W4363625980 hasPublicationYear "2023" @default.
• W4363625980 type Work @default.
• W4363625980 citedByCount "1" @default.
• W4363625980 countsByYear W43636259802023 @default.
• W4363625980 crossrefType "journal-article" @default.
• W4363625980 hasAuthorship W4363625980A5008643924 @default.
• W4363625980 hasAuthorship W4363625980A5010584350 @default.
• W4363625980 hasAuthorship W4363625980A5016948885 @default.
• W4363625980 hasAuthorship W4363625980A5033087588 @default.
• W4363625980 hasAuthorship W4363625980A5042301449 @default.
• W4363625980 hasAuthorship W4363625980A5052958094 @default.
• W4363625980 hasAuthorship W4363625980A5069823694 @default.
• W4363625980 hasAuthorship W4363625980A5082985646 @default.
• W4363625980 hasAuthorship W4363625980A5084847095 @default.
• W4363625980 hasAuthorship W4363625980A5084870834 @default.
• W4363625980 hasAuthorship W4363625980A5085952795 @default.
• W4363625980 hasAuthorship W4363625980A5091554389 @default.
• W4363625980 hasBestOaLocation W43636259801 @default.
• W4363625980 hasConcept C121608353 @default.
• W4363625980 hasConcept C126322002 @default.
• W4363625980 hasConcept C143998085 @default.
• W4363625980 hasConcept C185592680 @default.
• W4363625980 hasConcept C190283241 @default.
• W4363625980 hasConcept C2776694085 @default.
• W4363625980 hasConcept C2777292972 @default.
• W4363625980 hasConcept C2777609662 @default.
• W4363625980 hasConcept C31760486 @default.
• W4363625980 hasConcept C55493867 @default.
• W4363625980 hasConcept C71924100 @default.
• W4363625980 hasConcept C86554907 @default.
• W4363625980 hasConcept C90924648 @default.
• W4363625980 hasConceptScore W4363625980C121608353 @default.
• W4363625980 hasConceptScore W4363625980C126322002 @default.
• W4363625980 hasConceptScore W4363625980C143998085 @default.
• W4363625980 hasConceptScore W4363625980C185592680 @default.
• W4363625980 hasConceptScore W4363625980C190283241 @default.
• W4363625980 hasConceptScore W4363625980C2776694085 @default.
• W4363625980 hasConceptScore W4363625980C2777292972 @default.
• W4363625980 hasConceptScore W4363625980C2777609662 @default.
• W4363625980 hasConceptScore W4363625980C31760486 @default.
• W4363625980 hasConceptScore W4363625980C55493867 @default.
• W4363625980 hasConceptScore W4363625980C71924100 @default.
• W4363625980 hasConceptScore W4363625980C86554907 @default.
• W4363625980 hasConceptScore W4363625980C90924648 @default.
• W4363625980 hasFunder F4320307770 @default.
• W4363625980 hasFunder F4320321292 @default.
• W4363625980 hasIssue "9" @default.
• W4363625980 hasLocation W43636259801 @default.
• W4363625980 hasLocation W43636259802 @default.
• W4363625980 hasLocation W43636259803 @default.
• W4363625980 hasOpenAccess W4363625980 @default.
• W4363625980 hasPrimaryLocation W43636259801 @default.
• W4363625980 hasRelatedWork W2074517075 @default.
• W4363625980 hasRelatedWork W2077739050 @default.
• W4363625980 hasRelatedWork W2087724775 @default.
• W4363625980 hasRelatedWork W2167243939 @default.
• W4363625980 hasRelatedWork W2587680012 @default.
• W4363625980 hasRelatedWork W2884617011 @default.
• W4363625980 hasRelatedWork W3024085365 @default.
• W4363625980 hasRelatedWork W3044672584 @default.
• W4363625980 hasRelatedWork W3146426108 @default.
• W4363625980 hasRelatedWork W4255321854 @default.

• next